DONNA MCCORMICK: Open Payments
NPI 1255494902 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 58 payments from 13 companies in 2025. Trend: 2023 $1,374 · 2024 $972 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 23 | $396 |
| ABBVIE INC. | 16 | $244 |
| Intra-Sana Laboratories | 3 | $135 |
| Novo Nordisk Inc | 4 | $74 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Lilly USA, LLC | 2 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Tris Pharma Inc | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $19 |
Products named: CAPLYTA, RELTONE 200 MG, VRAYLAR, QULIPTA, Wegovy, UBRELVY, REXULTI, MOUNJARO.
Industry payments across TN — which companies pay providers there.
